- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01486394
Sonography in an Unselected Population of Acute Admitted Patients With Respiratory Symptoms
August 2, 2013 updated by: Christian Borbjerg Laursen, Odense University Hospital
Focused Sonographic Examination of the Heart, Lungs and Deep Veins in an Unselected Population of Acute Admitted Patients With Respiratory Symptoms: a Randomised Clinical Trial
The purpose of this study is to determine whether focused sonography of the heart, lungs and deep veins can increase the number of patients with respiratory symptoms correctly diagnosed in an emergency department.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
315
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Fyn
-
Odense, Fyn, Denmark, 5000
- Odense University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion criteria:
All 4 of the following must be present:
- The sonographic examination can be performed before or within 1 hour after the primary evaluation
- Patient is 18 years or older
- Patient able and willing to give informed consent
One ore more of the following symptoms or clinical findings at admission to the emergency department
- Respiratory rate > 20 breaths per minute
- Saturation < 95%
- Oxygen therapy initiated
- The patient has a principal complaint of dyspnoea
- The patient has a principal complaint of coughing
- The patient has a principal complaint of chest pain
Exclusion Criteria:
One of the following:
- The sonographic examination can not be performed within 1 hour after the primary evaluation
- The patient is 17 years or younger
- The patient not able or willing to give informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Focused sonography
Intervention group: After the primary evaluation by a physician in the emergency department, focused sonography of the patients heart, lungs and deep veins in the legs are performed.
Hereafter the further examinations and treatment are done according to hospital guidelines.
|
The patient is randomised to either a control group where usual treatment and diagnostic work-up is performed or to an intervention group where usual treatment and diagnostic workup are supplemented by a sonographic examination of the heart, lungs and deep veins are performed within one hour after the primary evaluation.
The primary evaluation is defined as the first evaluation of the patient by a physician in the Acute Medical Admission Department.
|
No Intervention: Usual treatment and diagnostic work-up
Control group: After the primary evaluation by a physician in the emergency department.
Hereafter the further examinations and treatment are done according to hospital guidelines.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The number of patients with a correct presumptive diagnosis within 4 hours after hospital admission.
Time Frame: 4 hours after hospital admission
|
The 4-hour presumptive diagnosis are compared to the final diagnosis obtained by audit after the patient has been discharged from the hospital (gold standard).
|
4 hours after hospital admission
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of patients with a correct presumptive diagnosis after primary evaluation in the control group and after sonography in the intervention group.
Time Frame: Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Sensitivity, specificity, positive predictive values, negative predictive values and diagnostic accuracy of the primary evaluation and the "4-hour" presumptive diagnosis.
Time Frame: Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Number of patients receiving appropriate, inappropriate and no specific treatment 4-hours after admission
Time Frame: Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
30 day mortality
Time Frame: 30 days after the patient has been admitted to the hospital
|
30 days after the patient has been admitted to the hospital
|
In-hospital mortality
Time Frame: Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Number of patients transferred to an intensive care unit
Time Frame: Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Number of patients given an appropriate, inappropriate and no specific treatment after primary evaluation in the control group and after sonography in the intervention group
Time Frame: Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Time to diagnostic / therapeutic thoracocentesis
Time Frame: Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Length of hospital stay
Time Frame: Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Participants will be followed for the duration of the hospital stay, an expected range of up to 5 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Christian B Laursen, M.D, Odense University Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Laursen CB, Sloth E, Lassen AT, Christensen Rd, Lambrechtsen J, Madsen PH, Henriksen DP, Davidsen JR, Rasmussen F. Point-of-care ultrasonography in patients admitted with respiratory symptoms: a single-blind, randomised controlled trial. Lancet Respir Med. 2014 Aug;2(8):638-46. doi: 10.1016/S2213-2600(14)70135-3. Epub 2014 Jul 3.
- Laursen CB, Sloth E, Lassen AT, Christensen RD, Lambrechtsen J, Madsen PH, Henriksen DP, Davidsen JR, Rasmussen F. Focused sonographic examination of the heart, lungs and deep veins in an unselected population of acute admitted patients with respiratory symptoms: a protocol for a prospective, blinded, randomised controlled trial. BMJ Open. 2012 May 30;2(3):e001369. doi: 10.1136/bmjopen-2012-001369. Print 2012.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2011
Primary Completion (Actual)
April 1, 2013
Study Completion (Actual)
April 1, 2013
Study Registration Dates
First Submitted
December 1, 2011
First Submitted That Met QC Criteria
December 2, 2011
First Posted (Estimate)
December 6, 2011
Study Record Updates
Last Update Posted (Estimate)
August 5, 2013
Last Update Submitted That Met QC Criteria
August 2, 2013
Last Verified
August 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S-2010074
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cough
-
Trevi TherapeuticsRecruitingRefractory Chronic CoughCanada, United Kingdom
-
Respivant Sciences GmbHRespivant Sciences Inc.TerminatedChronic Cough | IPF | Persistent Cough in IPFUnited States, United Kingdom, Netherlands, Australia, Belgium, New Zealand, Turkey, Italy, Germany, Czechia, Canada
-
The First Affiliated Hospital of Zhejiang Chinese...Completed
-
ILiAD BiotechnologiesCompletedPertussis/Whooping Cough | Bordetella Pertussis, Whooping CoughUnited Kingdom
-
KK Women's and Children's HospitalSingapore University of Technology and DesignUnknownCough | URTI | Cough Variant Asthma | Cough; Bronchial, With Grippe or InfluenzaSingapore
-
Shanghai Zhongshan HospitalNot yet recruitingSufentanil-induced Cough
-
Merck Sharp & Dohme LLCCompletedChronic CoughCanada, Czechia, Denmark, Hungary, Peru, Poland, Ukraine, United Kingdom, United States, Australia, China, Colombia, Germany, Guatemala, Israel, Italy, Malaysia, New Zealand, South Africa, Turkey
-
Khon Kaen UniversityCompleted
-
PhytoHealth CorporationCompleted
Clinical Trials on Focused Sonography of the heart, lungs and deep veins
-
Euromedic Specialist Clinics, PolandCompletedChronic Cerebrospinal Venous InsufficiencyPoland
-
Slagelse HospitalOdense University Hospital; Zealand University Hospital; Hvidovre University... and other collaboratorsCompleted
-
James F. Holmes, MD, MPHEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingWounds and Injuries | Abdomen, Acute | Abdominal Injury | Blunt Trauma to Abdomen | Abdomen InjuryUnited States
-
Lawson Health Research InstituteCompleted
-
Medtronic Atrial Fibrillation SolutionsMedtronicCompletedSymptomatic Paroxysmal Atrial Fibrillation (PAF)Germany, Czechia, France, Hungary, Italy, Netherlands, Spain, Switzerland
-
Saint Petersburg State University, RussiaNot yet recruitingIschemic Heart Disease | Mitral Insufficiency | Aortic Stenosis, Severe | Mitral Stenosis | Aortic Insufficiency | Ascending Aortic Aneurysm | Mitral Stenosis With Insufficiency | Tricuspid InsufficiencyRussian Federation
-
National Research Center for Preventive MedicineI.M. Sechenov First Moscow State Medical UniversityCompletedAtrial FibrillationRussian Federation
-
University of PadovaCompletedDeep Vein Thrombosis of the Lower Extremities
-
S. Anna HospitalUnknownCardiovascular Diseases | Emergencies | Neurovascular DisordersItaly
-
Gaziantep Islam Science and Technology UniversityDuygu Ayar; Ayşe EminoğluNot yet recruiting